BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3954277)

  • 21. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
    Durham JD; Caputo C; Dokko J; Zaharakis T; Pahlavan M; Keltz J; Dutka P; Marzo K; Maesaka JK; Fishbane S
    Kidney Int; 2002 Dec; 62(6):2202-7. PubMed ID: 12427146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography.
    Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
    Int J Cardiovasc Imaging; 2017 May; 33(5):595-604. PubMed ID: 27995343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography.
    Madsen TE; Pearson RR; Muhlestein JB; Lappé DL; Bair TL; Horne BD; Anderson JL;
    Crit Pathw Cardiol; 2009 Dec; 8(4):167-71. PubMed ID: 19952552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute renal dysfunction after major arteriography.
    Gomes AS; Baker JD; Martin-Paredero V; Dixon SM; Takiff H; Machleder HI; Moore WS
    AJR Am J Roentgenol; 1985 Dec; 145(6):1249-53. PubMed ID: 3877430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac catheterization and postoperative acute kidney failure in congenital heart pediatric patients.
    Bianchi P; Carboni G; Pesce G; Isgrò G; Carlucci C; Frigiola A; Giamberti A; Ranucci M
    Anesth Analg; 2013 Aug; 117(2):455-61. PubMed ID: 23780421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
    Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.
    Vogt B; Ferrari P; Schönholzer C; Marti HP; Mohaupt M; Wiederkehr M; Cereghetti C; Serra A; Huynh-Do U; Uehlinger D; Frey FJ
    Am J Med; 2001 Dec; 111(9):692-8. PubMed ID: 11747848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors for contrast-related acute kidney injury according to risk, injury, failure, loss, and end-stage criteria in patients with coronary interventions.
    Pakfetrat M; Nikoo MH; Malekmakan L; Tabande M; Roozbeh J; Reisjalali G; Zare N; Khajedehi P
    Iran J Kidney Dis; 2010 Apr; 4(2):116-22. PubMed ID: 20404421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiocontrast-induced acute renal failure.
    Weisbord SD; Palevsky PM
    J Intensive Care Med; 2005; 20(2):63-75. PubMed ID: 15855219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography.
    Traub SJ; Kellum JA; Tang A; Cataldo L; Kancharla A; Shapiro NI
    Acad Emerg Med; 2013 Jan; 20(1):40-5. PubMed ID: 23570477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy in patients with mild pre-existing renal impairment: a meta-analysis.
    Ho KM; Morgan DJ
    Anaesth Intensive Care; 2008 Sep; 36(5):646-53. PubMed ID: 18853581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
    An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium bicarbonate versus isotonic saline for the prevention of contrast-induced nephropathy in patients with diabetes mellitus undergoing coronary angiography and/or intervention: a multicenter prospective randomized study.
    Koc F; Ozdemir K; Altunkas F; Celik A; Dogdu O; Karayakali M; Gul EE; Erkorkmaz U; Kadi H; Akpek M; Kaya MG
    J Investig Med; 2013 Jun; 61(5):872-7. PubMed ID: 23552179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
    Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
    Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
    Merkle M; Sauter M; Argirov M; Wörnle M
    Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
    G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K; Alexopoulos E; Kyrzopoulos S; Iokovis P; Greenwood DC; Manginas A; Voudris V; Pavlides G; Buller CE; Kremastinos D; Cokkinos DV
    Circulation; 2004 Nov; 110(18):2837-42. PubMed ID: 15492300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.